Compare ZYME & NOMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZYME | NOMD |
|---|---|---|
| Founded | 2003 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.4B |
| IPO Year | 2022 | 2015 |
| Metric | ZYME | NOMD |
|---|---|---|
| Price | $22.88 | $9.84 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 4 |
| Target Price | ★ $38.90 | $14.25 |
| AVG Volume (30 Days) | 630.3K | ★ 1.8M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.12% |
| EPS Growth | ★ 33.33 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $105,965,000.00 | N/A |
| Revenue This Year | $162.82 | N/A |
| Revenue Next Year | N/A | $0.36 |
| P/E Ratio | ★ N/A | $8.38 |
| Revenue Growth | ★ 38.87 | N/A |
| 52 Week Low | $9.03 | $9.54 |
| 52 Week High | $28.49 | $20.14 |
| Indicator | ZYME | NOMD |
|---|---|---|
| Relative Strength Index (RSI) | 43.81 | 24.74 |
| Support Level | $22.23 | N/A |
| Resistance Level | $23.66 | $12.36 |
| Average True Range (ATR) | 1.42 | 0.41 |
| MACD | -0.05 | -0.15 |
| Stochastic Oscillator | 9.06 | 8.45 |
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.
Nomad Foods Ltd is a packaged foods company that is involved in the business of manufacturing and distributing branded frozen foods in Western Europe. The company manufactures and markets frozen food products such as fish, vegetables, poultry, Ice Cream, and ready meals like pizza. It sells its products through large grocery retailers under the brand Birds Eye in the United Kingdom and Ireland, Findus in Italy, France, Spain, and Iglo in Germany and other continental markets. The company operates through a single segment being Frozen. The majority of the revenue is generated from the United Kingdom.